|
RNF19B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.559400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.524900E-03 |
| Normal-vs-Stage2 |
7.577200E-01 |
| Normal-vs-Stage3 |
2.479500E-03 |
| Normal-vs-Stage4 |
6.796500E-03 |
| Stage1-vs-Stage2 |
5.283800E-02 |
| Stage1-vs-Stage3 |
3.980000E-01 |
| Stage1-vs-Stage4 |
6.302200E-01 |
| Stage2-vs-Stage3 |
3.489800E-02 |
| Stage2-vs-Stage4 |
5.506400E-02 |
| Stage3-vs-Stage4 |
8.570400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.600000E-03 |
| Normal-vs-AfricanAmerican |
4.061400E-03 |
| Normal-vs-Asian |
2.762300E-03 |
| Caucasian-vs-AfricanAmerican |
2.317800E-01 |
| Caucasian-vs-Asian |
1.477620E-01 |
| AfricanAmerican-vs-Asian |
9.515600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.618200E-03 |
| Normal-vs-Female |
3.777800E-03 |
| Male-vs-Female |
8.446800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.787200E-04 |
| Normal-vs-Age(41-60Yrs) |
3.695700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.300610E-01 |
| Normal-vs-Age(81-100Yrs) |
9.888500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.199800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.754500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.290800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.621800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.988400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.833040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.442400E-01 |
| Classical-VS-Follicular |
3.99389999999888E-05 |
| Classical-VS-Other |
7.490000E-02 |
| Classical-VS-Normal |
1.238290E-04 |
| Tall-VS-Follicular |
3.855400E-03 |
| Tall-VS-Other |
3.090000E-02 |
| Tall-VS-Normal |
3.777900E-03 |
| Follicular-VS-Other |
7.654800E-01 |
| Follicular-VS-Normal |
8.786800E-01 |
| Other-VS-Normal |
6.106200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.903960E-02 |
| Normal-vs-N1 |
1.747160E-01 |
| N0-vs-N1 |
5.085000E-01 |
|
|
